|
|
|
51-200 employees
View all
|
|
Biotechnology
|
|
6 Tide St, Boston, Massachusetts 02210, US
|
|
Entrada Therapeutics | 6,693 followers on LinkedIn. Entrada's mission is to transform the treatment of devastating diseases with intracellular therapeutics. | Entrada Therapeutics is a biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines, Endosomal Escape Vehicles (EEV™), to engage intracellular targets that have long been considered inaccessible and undruggable. The Company’s EEV therapeutics are designed to enable the efficient intracellular delivery of a wide range of therapeutics into a variety of organs and tissues with an improved therapeutic index. Through its proprietary, highly versatile and modular EEV Platform, Entrada is building a robust development portfolio of oligonucleotide-, antibody- and enzyme-based programs for the potential treatment of neuromuscular disease, immunology, oncology and diseases of the central nervous system.
|
Entrada Therapeutics Email Formats | Example Email Formats | Percentage |
---|---|---|
{first} | [email protected] |
75%
|
The widely used Entrada Therapeutics email format is {first} (e.g. [email protected]) with 75% adoption across the company.
To contact Entrada Therapeutics customer service number in your country click here to find.
Mary Magoon is the CEO of Entrada Therapeutics. To contact Mary Magoon email at [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.